Skip to content

Evaluation of advanced dressing procedure in comparison with the standard dressing procedure for Healing long-term Wounds

A Comparative Study on the Efficacy of Advanced PRF (A-PRF) versus Standard PRF (S-PRF) in treating Chronic Wounds, An Open-Label, Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/071302
Enrollment
40
Registered
2024-07-25
Start date
Unknown
Completion date
Unknown
Last updated
2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: 8- Other Procedures

Interventions

Intervention1: Advanced Platelet-Rich Fibrin (A-PRF): 15ml of venous blood will be drawn from the patients arm and centrifuged at 1500 rpm for 14 minutes to obtain A-PRF clots. Dressing procedure will

Sponsors

Dr Ranganath V S
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Participants with chronic wound for more than six weeks and have failed to heal by conventional treatments. Wound size of less than 20cm2. Both male and female participants. Age 20 years or older. Have a normal platelet count in range of 1,50,000- 4,50,000 cells/mm3. Have a normal PT time: 11- 16 seconds. Ability to provide informed consent or have a legally authorized representative able to provide consent on behalf of the participant. Willingness to comply with study procedures and follow-up visits. Adequate understanding of the study requirements and ability to communicate with study personnel.

Exclusion criteria

Exclusion criteria: Presence of an active infection at the ulcer site. Patients on anticoagulants (warfarin, heparin). Pregnant and lactating women. Patients suffering from leukaemia, septicaemia, impaired platelet function or other haematological disorders. Patients with hypoproteinaemia. Patients taking long term steroid containing drugs or using steroid ointments on wounds.

Design outcomes

Primary

MeasureTime frame
Change in mean size reduction of wound area from the baseline wound size.Timepoint: Evaluation of wound size at week 2 and week 4 from baseline.

Secondary

MeasureTime frame
Participants Quality of Life using Wound QoL-17 Questionnaire.Timepoint: Evaluation of Participants Quality of Life at week 2 and week 4 from baseline.

Countries

India

Contacts

Public ContactJasmine S

Gautham College of Pharmacy

adithyavh@gmail.com9008427619

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026